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ABSTRACT
In mammalian nucleotide excision repair, the DDB1–
DDB2 complex recognizes UV-induced DNA photole-
sions and facilitates recruitment of the XPC com-
plex. Upon binding to damaged DNA, the Cullin 4
ubiquitin ligase associated with DDB1–DDB2 is ac-
tivated and ubiquitinates DDB2 and XPC. The struc-
turally disordered N-terminal tail of DDB2 contains
seven lysines identified as major sites for ubiquiti-
nation that target the protein for proteasomal degra-
dation; however, the precise biological functions of
these modifications remained unknown. By exoge-
nous expression of mutant DDB2 proteins in normal
human fibroblasts, here we show that the N-terminal
tail of DDB2 is involved in regulation of cellular re-
sponses to UV. By striking contrast with behaviors
of exogenous DDB2, the endogenous DDB2 protein
was stabilized even after UV irradiation as a function
of the XPC expression level. Furthermore, XPC com-
petitively suppressed ubiquitination of DDB2 in vitro,
and this effect was significantly promoted by centrin-
2, which augments the DNA damage-recognition ac-
tivity of XPC. Based on these findings, we propose
that in cells exposed to UV, DDB2 is protected by XPC
from ubiquitination and degradation in a stochastic
manner; thus XPC allows DDB2 to initiate multiple
rounds of repair events, thereby contributing to the
persistence of cellular DNA repair capacity.
INTRODUCTION
Genomic DNA continuously suffers damage from a
plethora of sources, including the intrinsic instability of
DNA, endogenously produced reactive oxygen species or
other metabolites, and environmental agents such as radi-
ation and chemical compounds. DNA damage interferes
with DNA replication and transcription, and thereby in-
duces mutations, chromosomal aberrations, cellular senes-
cence, and apoptosis. Ultraviolet light (UV), one of the
most common sources of DNA damage from the envi-
ronment, induces characteristic dipyrimidinic DNA pho-
tolesions; e.g. cyclobutane pyrimidine dimers (CPDs) and
pyrimidine–pyrimidone (6-4) photoproducts (6-4PPs). In
mammals, these UV-induced photolesions are eliminated
exclusively through a major DNA repair pathway, nu-
cleotide excision repair (NER). Hereditary defects in NER
are associated with several human autosomal recessive dis-
orders, such as xeroderma pigmentosum (XP), which is clin-
ically characterized by cutaneous hypersensitivity to sun-
light and a remarkable predisposition to skin cancer (for
recent reviews, see (1,2)).
A key step in DNA repair is the initial recognition of
DNA damage. In mammalian NER, there are two sub-
pathways, as follows: the global genomic NER (GG-NER)
surveys the entire genome, whereas transcription-coupled
NER (TC-NER) specifically removes RNA polymerase II-
blocking lesions on template DNA strands during tran-
scription. In particular, GG-NER decreases the frequency
of replication forks that encounter DNA damage, thereby
preventing mutagenesis and carcinogenesis. The XP-related
protein XPC plays a crucial role (3–5). XPC forms a het-
erotrimeric complex with either of the two mammalian or-
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thologues of Saccharomyces cerevisiae Rad23 (RAD23A
and B) and centrin-2, a small calcium-binding EF-hand
protein (6–8). In the cell-free NER reaction, the XPC com-
plex functions as the initiator, and it has specific binding
affinities not only for DNA containing a variety of helix-
distorting base lesions, such as UV-induced 6-4PPs and
bulky chemical adducts, but also for undamagedDNA con-
taining mismatched bases (9,10). These biochemical stud-
ies, as well as a structural study of the S. cerevisiae XPC
orthologue, Rad4 (11), have revealed that XPC/Rad4 in-
directly senses structural abnormalities of DNA through
interactions with the undamaged portion of the DNA du-
plex, in particular with the two ‘normal’ bases opposite the
damaged site that oscillate due to impaired base pairing.
Although this ‘indirect readout’ model for damage recog-
nition plausibly explains the broad spectrum of substrate
specificities associated with GG-NER, it also implies that
XPC by itself is incapable of distinguishing whether dam-
age that should be processed byNER is indeed present. This
problem seems to be solved by a subsequent ‘damage ver-
ification’ step involving the basal transcription factor IIH
(TFIIH) complex and the XPA protein, which prevents ad-
verse incisions at sites devoid of damage. When TFIIH is
recruited by DNA-bound XPC, two ATP-dependent heli-
case subunits, XPB and XPD, locally unwind the duplex
DNA, allowing XPD (presumably together with XPA) to
start translocation along a specific DNA strand in the 5’-3’
direction (12,13). The presence of damage is finally verified
by blocking of XPD translocation, a process to which XPA
may also contribute by recognizing a specific configuration
of the complex containing kinked DNA (14,15). Upon ver-
ification of damage, other NER factors, such as replication
protein A (RPA) and the two structure-specific endonucle-
ases XPG and ERCC1-XPF, are recruited to accomplish
dual incision and removal of damage (3).
Although XPC is responsible for the primary recog-
nition of virtually all lesions within the huge repertoire
of GG-NER substrates, UV-induced photolesions also re-
cruit a specific additional factor for their detection and re-
pair. The DDB1–DDB2 heterodimer, also designated as the
UV-damaged DNA-binding protein complex (UV-DDB),
specifically binds 6-4PPs with extremely high affinity and
CPDs with moderate affinity (16,17), creating sites to which
XPC is recruited (18–20). This mechanism is particularly
relevant for the repair of CPDs, a type of damage associ-
ated with very limited DNA helix distortions that are prone
to evade direct detection by XPC. By contrast, substan-
tial removal of 6-4PPs occurs in the absence of UV-DDB,
probably through direct recognition by XPC; however, UV-
DDB has been proposed to stimulate GG-NER of 6-4PPs,
especially when lesions are distributed sparsely throughout
the genome, e.g. after irradiation with relatively low UV
doses (19,21). The recently published crystal structure of
UV-DDB revealed that DDB2, but not DDB1, is responsi-
ble for interaction with damaged DNA (22,23). In contrast
to XPC, DDB2 has a C-terminal WD-repeat -propeller
domain that provides a hydrophobic pocket, which directly
accommodates the two affected pyrimidine residues flipped
out of the DNA duplex. In addition to its DNA-binding
-propeller domain, DDB2 has a structurally disordered
N-terminal tail and an intervening helix–loop–helix mo-
tif that mediates interaction with DDB1. DDB1 contains
three -propeller domains, one of which interacts with
the Cullin 4 (CUL4)–RBX1 ubiquitin ligase module to
form the CUL4–RBX1–DDB1–DDB2 (CRL4DDB2) ubiq-
uitin E3 ligase complex. DDB1 serves as a common adapter
subunit for this ubiquitin ligase family (24–26), whereas
DDB2 forms the substrate receptor and can be exchanged
with other CRL4 substrate receptors, such as CSA (27) and
CDT2 (28), to determine the substrate specificity of the lig-
ase. The E3 ligase involving DDB2 is activated upon bind-
ing to UV-damaged chromatin, leading to ubiquitination of
various nuclear proteins, including DDB2, XPC and his-
tonesH2A,H3 andH4 (29–31). This activation is accompa-
nied by dissociation from the COP9 signalosome, a negative
regulator of Cullin-containing E3 ligases and conjugation
of NEDD8 to CUL4 (22,27).
The roles of the CRL4DDB2-mediated ubiquitination are
somewhat controversial and remain to be understood. Sev-
eral lines of evidence indicate that following UV irradia-
tion, DDB2 undergoes poly-ubiquitination and degrada-
tion by the proteasome (32,33), for which lysine residues in
the N-terminal tail are essential (22). In our hands, a ma-
jority of ubiquitinated XPC seems to escape degradation
and revert to the unmodified form through deubiquitina-
tion (30), whereas other groups have argued that XPC un-
dergoes substantial UV-induced degradation (34,35). Based
on the observation that extensive poly-ubiquitination of
DDB2 in vitro abolishes the remarkable damaged DNA-
binding activity of UV-DDB, we proposed that CRL4DDB2-
mediated ubiquitination is important for efficient handover
of damage from UV-DDB to XPC and initiation of the
subsequent NER reaction (30,36). Although a very re-
cent report suggested that VCP/p97 segregase modulates
poly-ubiquitin chains on DDB2 and XPC to ensure effi-
cient NER (37), questions persist concerning the biolog-
ical significance of DDB2 degradation and XPC ubiqui-
tination. In this study, we further investigated the roles
for the CRL4DDB2-mediated ubiquitination, focusing espe-
cially on the damaged DNA-binding activity and degrada-
tion of DDB2. Our results provide a novel insight into the
role played by ubiquitination in regulating functional inter-
actions between the twoGG-NERdamage-recognition fac-
tors.
MATERIALS AND METHODS
Cell lines and cell culture
Human fibroblast cell lines WI38 VA13 (normal) and
XP4PASV (XPC-deficient) were cultured at 37◦C in Dul-
becco’s modified Eagle’s medium (Nissui) containing 10%
fetal bovine serum. High Five cells were cultured at 27◦C in
Ex-Cell 405 medium (SAFC Biosciences).
Establishment of stably transformed cell lines
The cDNA encoding HA-DDB2 was inserted into the bi-
cistronic expression vector pIREShyg (Takara Bio). Vari-
ous mutations in DDB2 were introduced into this construct
using the QuikChangeMutagenesis Kit (Agilent Technolo-
gies). These constructs were linearized and introduced into
WI38 VA13 cells by electroporation using a Gene Pulser II
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(Bio-Rad). Stable transformants were selected by culturing
cells in the presence of 200 g/ml hygromycin B (Life Tech-
nologies). XP4PASV cells expressing FLAG-XPC were es-
tablished as described previously (30).
Preparation of cell lysates
Cells in 60 mm dishes were washed twice with phosphate-
buffered saline (PBS) and lysed in situwith 0.5ml of ice-cold
CSK buffer [10 mM Pipes–NaOH (pH 6.8), 3 mM MgCl2,
1 mM EGTA, 33.3% sucrose, 0.1% Triton X-100] contain-
ing 0.3 M NaCl, 10 mM N-ethylmaleimide (NEM; Wako
Pure Chemicals), and protease inhibitor cocktail [0.25 mM
phenylmethylsulfonyl fluoride (PMSF; Sigma–Aldrich), 1
g/ml leupeptin, 2 g/ml aprotinin, 1 g/ml pepstatin and
50 g/ml Pefabloc SC (AEBSF); all inhibitors, except for
PMSF, were purchased from Roche Applied Science]. After
incubation on ice for 1 h, the cell lysates were scraped into
microfuge tubes and centrifuged for 10 min at 20 000 × g
to obtain soluble extracts. The resultant pellets were resus-
pended with the aid of sonication in 0.25 ml of the same
buffer.
Immunoprecipitation
Soluble cell extracts were mixed with 30 l of anti-HA
(3F10) agarose beads (Roche Applied Science) and incu-
bated overnight at 4◦C. After the beads were extensively
washed with CSK buffer containing 0.3 M NaCl, bound
proteins were eluted with SDS sample-buffer [62.5 mM
Tris–HCl (pH 6.8), 1% SDS, 10% glycerol, 0.02% bro-
mophenol blue].
Clonogenic cell survival assay
Two hundred cells were inoculated in a 100 mm culture dish
and irradiatedwith various doses ofUV-Cunder germicidal
lamps (GL-15: Toshiba) with a 254-nm peak. At 21 days
post-irradiation, the cells were washed twice with PBS, and
then stained with 0.1% crystal violet in 10% ethanol for 30
min at room temperature. The stained dishes were washed
with water, and colonies were counted.
Purified protein factors
The XPC–RAD23B complex, centrin-2 and the DDB1–
DDB2 complex were purified essentially as described pre-
viously (30,38). Recombinant baculovirus expressing His-
tagged human UBA1 protein (E1 for ubiquitination) was
generated using the Bac-to-Bac baculovirus expression sys-
tem (Life Technologies). Twenty 150 mm dishes of High
Five cells were infected with the baculovirus and incubated
at 27◦C for 3 days. The infected cells were then collected
and resuspended in 80 ml of buffer containing 25 mMTris–
HCl (pH 8.0), 1 mMEDTA, 0.3MNaCl, 1%Nonidet P-40,
10% glycerol, 1 mM dithiothreitol (DTT) and protease in-
hibitor cocktail. After incubation on ice for 30 min, the cell
lysate was centrifuged at 20 000 × g for 20 min, and the
resulting supernatant was dialyzed overnight against buffer
containing 5 mM potassium phosphate (pH 7.0), 0.1 mM
EDTA, 20 mM KCl, 10% glycerol, 1 mM DTT and 0.25
mMPMSF. The dialysate was centrifuged at 4◦C for 30 min
at 200 000 × g to yield clarified extract, which was loaded
onto a HiTrap DEAE FF column (5 ml: GE Healthcare
Biosciences) equilibrated with buffer A [5 mM potassium
phosphate (pH 7.0), 10% glycerol, 0.01% Triton X-100, 1
mM 2-mercaptoethanol, 0.25 mM PMSF] containing 20
mM KCl. After washing with the same buffer, bound pro-
teins were eluted with buffer A containing 0.5 M KCl. The
eluate was then loaded onto aHiTrap ChelatingHP column
(1ml: GEHealthcare Biosciences), which was pre-bound to
nickel ions and equilibrated with buffer B [20 mM sodium
phosphate (pH 7.8), 0.3 M NaCl, 10% glycerol, 0.01% Tri-
ton X-100, 1 mM 2-mercaptoethanol, 0.25 mM PMSF]
containing 5 mM imidazole. After washing with the same
buffer, the column was successively washed with buffer B
containing 20, 100 and 250 mM imidazole. The 20 and 100
mM imidazole fractions containing His-UBA1 were com-
bined, dialyzed against buffer C [25 mMTris–HCl (pH 7.5),
1 mM EDTA, 10% glycerol, 0.01% Triton X-100, 1 mM
DTT, 0.25 mM PMSF] containing 0.1 M NaCl, and fur-
ther loaded onto aMonoQHR5/5 column (GEHealthcare
Biosciences) equilibrated with the same buffer. The column
was developed with a linear NaCl gradient (12 ml) from 0.1
to 0.5M in buffer C; His-UBA1 eluted around 0.2MNaCl.
Reconstitution of CRL4DDB2 E3 ligase
The His6-tagged complex containing human CUL4A
(residues 38–759) and mouse RBX1 (residues 12–108)
was expressed and purified by Ni-NTA, anion-exchange
(POROS 50HQ; Life Technologies), and size-exclusion
(HiLoad 16/60 Superdex 200; GE Healthcare Biosciences)
column chromatography, essentially as described previously
(22). The separately purified complex (30 g) containing
FLAG-DDB1 and DDB2 (wild type or mutant) was incu-
bated on ice for 1 h with 90 g of the CUL4A–RBX1 com-
plex, and this mixture was then passed through a Superdex
200 PC 3.2/30 column (GE Healthcare Biosciences) equili-
brated with buffer containing 40 mM Tris–HCl (pH 7.5), 1
mM EDTA, 0.1 M NaCl, 10% glycerol, 0.01% Triton X-
100, 1 mM DTT and 0.25 mM PMSF. Eighty-microliter
fractions were collected, and the fractions containing the
four subunits were determined by SDS-PAGE followed by
silver staining.
Measurement of in vivo repair rates of UV-induced photole-
sions
Cells were cultured to 80% confluence in 100 mm dishes
and maintained at 37◦C for 2 h in medium containing 6
mM thymidine to prevent dilution of DNA lesions by repli-
cation. Cells were then irradiated with UV-C (at 10 J/m2
for 6-4PPs or at 2 J/m2 for CPDs) and cultured in the
presence of 6 mM thymidine for the indicated times to al-
low DNA repair. Genomic DNA was purified with the QI-
Aamp DNA Blood Mini Kit (Qiagen), and the levels of
remaining photolesions were determined using an enzyme-
linked immunosorbent assay with the lesion-specific anti-
bodies (64M-2 or TDM-2; Cosmo Bio).
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In vitro ubiquitination assay
The standard reaction mixture (15 l) contained 50 mM
Tris–HCl (pH 7.5), 5 mM MgCl2, 0.2 mM CaCl2, 2 mM
ATP, 1 mM DTT, 0.01% Triton X-100, bovine serum albu-
min (BSA; 1.5 g), UV-irradiated plasmid DNA (2 kJ/m2;
100 ng), E1 (12.5 ng), UbcH5a (1 g; Boston Biochem),
ubiquitin (10 g), purified CRL4DDB2 (50 ng) and XPC-
RAD23B. The amount of ubiquitin was reduced where in-
dicated. The reactions were incubated at 30◦C for 30 min,
stopped by addition of 1 l of 0.5 M EDTA, and subjected
to SDS-PAGE followed by immunoblot analyses using the
appropriate antibodies.
DNA-binding assay
Streptavidin-coated paramagnetic beads (Dynabeads M-
280 Streptavidin; Life Technologies) were used to immo-
bilize ligated arrays of a 30 mer double-stranded oligonu-
cleotide containing a 6-4PP, as described previously (30).
After in vitro ubiquitination reactions were carried out
in the presence of these DNA beads, proteins bound or
unbound to DNA were separated and subjected to im-
munoblot analyses.
Antibodies, immunoblotting and immunostaining
Anti-XPC (13) and anti-RAD23B (39) antibodies were ob-
tained as described previously. Anti-lamin B1 and CUL4
(Santa Cruz Biotechnology), anti-DDB1 (BD Biosciences),
anti-DDB2 (R&DSystems) and anti-HA (3F10: RocheAp-
plied Science) antibodies were purchased, respectively. For
immunoblot analyses, proteins separated by SDS-PAGE
were transferred onto Immobilon-P membranes (Merck
Millipore) and detected by chemiluminescence using the ap-
propriate secondary antibodies and substrates. Detection
and quantitation were performed on an ImageQuant LAS-
4010 biomolecular imager (GE Healthcare Biosciences).
Blots were also exposed to X-ray films. Immunofluores-
cence staining was carried out basically as described pre-
viously (40).
Mass spectrometry
Proteins were subjected to SDS-PAGE, followed by sil-
ver staining. The bands of interest were cut out and de-
colorized. After being alkylated with iodoacetamide, sam-
ples were digestedwith SequencingGradeModifiedTrypsin
(200 ng; Promega) for 18 h at 37◦C. The digested samples
were analyzed on an LTQ Orbitrap Discovery mass spec-
trometer (Thermo Scientific), and the MASCOT software
was used to determine ubiquitination sites.
Other materials and methods
Silver staining was carried out with 2D-Silver Stain II Kit
(Cosmo Bio) or, for mass spectrometry, the Silver Stain
MS Kit (Wako Pure Chemicals). Cycloheximide (Sigma–
Aldrich) and MG132 (Calbiochem) were purchased from
the indicated suppliers.
RESULTS
Lysine residues in the DDB2 N-terminal tail are involved in
cellular UV responses
The N-terminal tail of human DDB2 consists of approx-
imately 100 amino acids, and seven lysine residues are
present within the very N-terminal 40 amino acids. We pre-
viously reported that these lysines are targets for ubiquitina-
tion by CRL4DDB2 and are required for UV-induced degra-
dation of DDB2 itself (22). In the preceding study, trans-
formed cell lines were established from normal human fi-
broblasts (WI38 VA13), which stably expressed (in addi-
tion to endogenous DDB2) HA-tagged wild-type DDB2
(DDB2-WT) or mutant DDB2 with lysine-to-arginine sub-
stitutions at all seven lysines within the N-terminal tail
(DDB2-N7KR). To further investigate the roles of the N-
terminal tail, we established an additional cell line express-
ing HA-tagged DDB2 lacking the N-terminal 40 amino
acids (DDB2-Ndel) (Figure 1A). As shown previously with
DDB2-N7KR (22), DDB2-Ndel co-immunoprecipitated
with DDB1 (Supplementary Figure S1) and CUL4A (data
not shown) as efficiently as DDB2-WT, confirming that the
N-terminal tail does not affect assembly of the CRL4DDB2
complex. Using these transformed cell lines, we examined
the sensitivity to killing by UV. As shown in Figure 1B, ec-
topic expression of DDB2-WT conferred substantial UV
resistance to the parental WI38 VA13 cells; this effect was
slightly compromised by deletion of the N-terminal tail.
Notably, ectopic expression ofDDB2-N7KRdid not confer
any additional UV resistance on the parental WI38 VA13
cells (Figure 1B). As expected from the previous studies,
the cell line expressing DDB2-WT removed UV-induced 6-
4PPs from the genomic DNA at a comparable rate com-
pared with the parental cells (Figure 1C), whereas repair
of CPDs was slightly accelerated (Figure 1D). Similar re-
pair kinetics was observed with the cell line expressing
DDB2-Ndel or DDB2-N7KR, suggesting that the DDB2
N-terminal tail and, especially, the lysine residues within it
are involved in regulation of cellular UV responses, inde-
pendent of DNA repair activities.
N-terminal lysines differentially affect UV-induced degrada-
tion and chromatin binding of DDB2
We previously showed that ectopically expressed DDB2-
N7KR, but not DDB2-WT, is mostly resistant to UV-
induced degradation mediated by the proteasome (22). On
the other hand, poly-ubiquitinatedDDB2 loses its damaged
DNA-binding activity in vitro, suggesting that ubiquitina-
tion plays a role in dissociation of UV-DDB from sites of
DNA damage, which we hypothesized may promote han-
dover of damage to XPC (30). To investigate whether elim-
ination of the major ubiquitination sites would affect the
DNA-binding properties of DDB2 in vivo, the aforemen-
tioned cell lines were treated with UV and, at various time
points, fractionated into soluble extracts and insoluble ma-
terials containing chromatin-bound proteins. Immunofluo-
rescence analyses confirmed that the expressed HA-DDB2
proteins localized predominantly within the nucleus regard-
less of the presence or absence of mutation (Supplementary
Figure S2).
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Figure 1. UV sensitivity and global genomic nucleotide excision repair (GG-NER) activity of transformed human fibroblast cell lines ectopically expressing
wild-type or mutant DDB2 protein. (A) Immunoblot analyses of parental WI38 VA13 cells and transformed cell lines ectopically expressing various DDB2
proteins. RAD23B was used as a loading control. Note that reactivity of the anti-DDB2 antibody is slightly compromised by mutations in the N-terminal
tail. (B) Clonogenic UV survival assay of the established cell lines. (C andD) Repair kinetics of UV-induced 6-4PPs (C) and CPDs (D). The XPC-deficient
cell line (XP4PASV) was used as a negative control. For (B), (C) and (D), mean values and standard errors were calculated from three independent
experiments.
When the ectopically expressed DDB2 was detected by
immunoblotting with anti-HA antibody, all DDB2 species
(WT, Ndel and N7KR) transiently associated with chro-
matin, peaking around 0.5–1 h after irradiation (Supple-
mentary Figure S3). In response to UV, a slight decrease in
protein levels was discerned for DDB2-WT, but not DDB2-
Ndel or -N7KR. This difference was dramatically larger
when similar experiments were carried out in the presence
of cycloheximide to inhibit de novo protein synthesis (Fig-
ure 2). Although transient chromatin association of DDB2-
WT was still observed, the total protein level was reduced
so rapidly that it mostly disappeared by 3 h post-irradiation.
By striking contrast, total levels of the two mutant DDB2
proteins appeared to persist even after UV irradiation, in
line with our previous findings regarding DDB2-N7KR
(22). Notably, as these mutant DDB2 proteins disappeared
from the chromatin fractions, they reverted to the soluble
fractions (most pronounced at 5 h post-UV). Taken to-
gether with the results in Figure 1C and D, these findings
demonstrate that the N-terminal lysine residues of DDB2
appear to be dispensable for dissociation of UV-DDB from
UV-damaged chromatin and normal NER processing.
Identification of DDB2 ubiquitination sites outside the N-
terminal tail
Our previous studies with cell-free ubiquitination assays in-
dicated that, apart from the major sites identified within the
N-terminal tail, DDB2 also contains a few additional sites
that can be targeted by auto-ubiquitination in vitro (22). It
is possible that poly-ubiquitination of DDB2 has different
functions depending on the sites that are modified; poly-
ubiquitination within the N-terminal tail may primarily be
responsible for UV-induced degradation of DDB2, whereas
poly-ubiquitination at other sites may regulate its interac-
tion with damaged DNA. To test this possibility, we next
tried to identify the ubiquitination sites in DDB2 outside
the N-terminal tail.
For this purpose, we prepared recombinant CRL4DDB2
complexes, which contained either DDB2-WT or DDB2-
Ndel in addition to FLAG-DDB1, CUL4A and RBX1
(Supplementary Figure S4A). These complexes were im-
mobilized on anti-FLAG antibody beads and used for in
vitro auto-ubiquitination reactions containing “K-less”mu-
tant ubiquitin, in which all lysine residues were changed
to arginines to prevent poly-ubiquitin chain formation.
After the beads were washed extensively, bound proteins
were eluted and subjected to SDS-PAGE, followed by sil-
ver staining. As shown in Supplementary Figure S4B, mul-
tiple bands corresponding to mono-ubiquitinated DDB2-
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Figure 2. Mutant DDB2 proteins lacking the N-terminal lysines bind to chromatin, but resist UV-induced degradation. Transformed cell lines expressing
indicatedHA-DDB2 (WT,Ndel or N7KR) were pre-treated for 2 h with 1mM cycloheximide (CHX), and then irradiated withUV-C at 10 J/m2. Following
further incubation for various times in the presence of CHX, the cells were fractionated into soluble extracts (sup) and insoluble materials (ppt), which
were then subjected to immunoblot analyses. RAD23B and lamin B1 were used to validate the fractionation, and also as loading controls.
Ndel were discernable, whereas modified DDB2-WT bands
were difficult to identify due to the presence of a larger num-
ber of ubiquitination sites, resulting in overlapping bands
on the gel. When mono-ubiquitinated DDB2-Ndel was di-
gested with trypsin and analyzed by mass spectrometry, at
least six lysine residues (K146, K151, K187, K233, K278,
K362) were found to undergo the modification. Based on
the diGly proteomics, it was reported that among these sites,
at least K151 and K187 indeed undergo ubiquitination in
vivo (41).
The X-ray crystal structures of the CRL4DDB2 complex
revealed that the catalytic center for ubiquitination, formed
on the C-terminal tip of the rod-shaped CUL4, could freely
move around within a certain range of space, the so-called
“ubiquitination zone” (22). The newly determined ubiq-
uitination sites reside within the -propeller domain of
DDB2 and, except for K362, five of them are expected to
be inside the ubiquitination zone. Because it was unlikely
that CUL4 could target K362 of DDB2 within the same
CRL4DDB2 complex, we decided to introduce lysine-to-
arginine substitutions at the remaining five sites in DDB2-
Ndel (designated as DDB2-Ndel/BP5KR). The recombi-
nant E3 ligase containing DDB2-Ndel/BP5KR was pre-
pared and used for in vitro ubiquitination reactions. In line
with our previous report (22), when normal ubiquitin was
included in the reactions, DDB2-Ndel underwent exten-
sive poly-ubiquitination and barely entered the gel (Fig-
ure 3, lanes 3–5). Under similar conditions, a majority of
DDB2-Ndel/BP5KR remained unmodified, indicating that
most of the ubiquitination sites in this mutant protein were
deleted, as expected (lanes 7–9). However, a very small frac-
tion of DDB2-Ndel/BP5KR still seemed to undergomono-
or poly-ubiquitination and parallel experiments with K-less
ubiquitin revealed the presence of a fewminor modification
sites (lanes 16–18).
To examine in vivo functions and behaviors of this
ubiquitination-resistant DDB2, we established a trans-
formed cell line from WI38 VA13, which stably expressed
HA-tagged DDB2-Ndel/BP5KR (Figure 4A). As shown in
Figure 4B, this cell line was slightly more sensitive to UV
than the parental cells, although the ectopic expression of
DDB2-Ndel conferred significant UV resistance. Further-
more, this cell line exhibited significantly slower repair of
6-4PPs following UV irradiation (Figure 4C), whereas the
enhanced repair of CPDs with the DDB2-Ndel expression
was also canceled (Figure 4D). Next the cells were exposed
to UV and fractionated into soluble extracts and insolu-
ble materials at various time points, as in Figure 2. DDB2-
Ndel/BP5KR lacking the N-terminal tail was resistant to
UV-induced degradation, as expected (Figure 4E and Sup-
plementary Figure S5). Although it seemed to bind chro-
matin normally uponUV irradiation,DDB2-Ndel/BP5KR
tended to reside longer on chromatin; however, the level of
the chromatin-bound protein eventually decreased, suggest-
ing that this mutant DDB2 protein was nonetheless able to
dissociate from sites with DNA damage.
Poly-ubiquitination abrogates damaged DNA binding by
DDB2, regardless of which sites are modified
To determine the site at which DDB2 ubiquitination mod-
ulates damaged DNA-binding activity, two DDB2 mutant
proteins were used for in vitro ubiquitination and DNA-
binding assays; DDB2-BP5KR had the intact N-terminal
tail but lacked the five ubiquitination sites in the -propeller
domain, whereas DDB2-N7KR lacked the seven lysines
in the N-terminal tail, so ubiquitination of this protein
could occur only in the -propeller domain. CRL4DDB2
complexes containing one of these mutant DDB2 proteins
were prepared and used for cell-free ubiquitination reac-
tions in the presence of paramagnetic beads bearing im-
mobilized DNA containing UV-induced 6-4PPs. After the
reactions, DNA-bound and -unbound proteins were sep-
arated and detected by immunoblotting (Figure 5). As
shown in our previous study (30), almost all of the unmod-
ified DDB2-WT bound to the damaged DNA beads (com-
pare lanes 1 and 4), whereas poly-ubiquitinated DDB2-
WT was recovered mostly in the unbound fraction (lanes
2 and 5). When K-less ubiquitin was used instead of nor-
mal ubiquitin, DDB2-WT predominantly remained bound
to damaged DNA (lanes 3 and 6), corroborating the idea
that mono-ubiquitination cannot compromise the damage-
recognition activity of DDB2, even when it occurs at mul-
tiple sites. Because essentially the same results were ob-
tained with DDB2-N7KR (lanes 7–12) and DDB2-BP5KR
(lanes 13–18), we conclude that poly-ubiquitination abol-
ishes damaged DNA-binding activity of DDB2, regard-
less of which sites are modified. In a similar experi-
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ment, DDB2-Ndel behaved indistinguishably from DDB2-
N7KR, whereas DDB2-Ndel/BP5KR poorly underwent
poly-ubiquitination and thus tended to be retained by dam-
aged DNA (Supplementary Figure S6).
XPC negatively regulates UV-induced degradation of DDB2
The results described above concerning ubiquitination-
resistant DDB2 suggest that poly-ubiquitination of DDB2
is not essential for dissociation from UV-damaged chro-
matin, although it may promote dissociation. This obser-
vation prompted us to reexamine behaviors of endoge-
nously expressed DDB2 in response to UV irradiation.
When WI38 VA13 cells were treated with UV and fraction-
ated as described above, we noticed that degradation of en-
dogenous DDB2 was not as pronounced as that of ectopi-
cally expressed DDB2-WT, despite the presence of the in-
tact N-terminal tail (Figure 6A, left panel). Even in the ab-
sence of de novo protein synthesis, a portion of chromatin-
bound DDB2 reverted to the soluble extract at later time
points. By contrast, in the XPC-deficient human fibroblast
cell line (XP4PASV), endogenous DDB2 was extremely un-
stable after exposure to UV (Figure 6A, right panel). This
UV-induced destabilization of endogenous DDB2 was sim-
ilarly observed with XP4PASV cells that were not treated
with cycloheximide (Supplementary Figure S7). To deter-
mine whether the observed difference in DDB2 stability
could be attributed to the presence or absence of XPC, we
took advantage of XP4PASV-derived transformed cell lines
that stably expressed FLAG-XPC either at a nearly phys-
iological level or at a much higher level (Figure 6B). In
these cell lines, the UV-induced destabilization of endoge-
nous DDB2 was dramatically alleviated, and this effect ap-
peared to depend on expression levels of XPC (Figure 6C;
see also quantitative data in Figure 6D). Furthermore, we
have previously reported that the W690S mutation of XPC,
identified from a patient with XP group C, completely abol-
ishes its DNA binding activity, although this mutant XPC
protein in vivo is still recruited to the sites with UV-induced
DNA damage in a DDB2-dependent manner (42). When
this mutant version of FLAG-XPC was stably expressed in
XP4PASV cells, endogenous DDB2 showed similar insta-
bility upon UV treatment as observed in the parental cells
(Supplementary Figure S8), indicating that the DNA bind-
ing activity of XPC is crucial to counteract the UV-induced
destabilization of DDB2.
The results described above strongly suggest that DDB2
in vivo does not always undergo degradation even upon
binding to UV-induced photolesions. As long as XPC is
properly recruited, CRL4DDB2 bound toDNA damage may
preferentially target XPC, allowing the N-terminal tail of
DDB2 to escape poly-ubiquitination, which, in turn, en-
ables DDB2 to be involved in multiple rounds of damage
recognition (Figure 7A). To test this possibility, we next ex-
amined how XPC affects ubiquitination of DDB2 in vitro.
When ubiquitin at sub-optimal concentrationswas included
in the reactions, the presence of XPC significantly sup-
pressed ubiquitination of DDB2 (Figure 7B). Notably, this
inhibitory effect of XPC was much more pronounced in the
presence of centrin-2, which interacts with XPC and aug-
ments its ability to recognize DNA damage (38,43); our in
vitro ubiquitination assays contained UV-irradiated DNA,
which significantly stimulates CRL4DDB2-mediated ubiqui-
tination. Consistent results were obtained when the XPC
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DDB2 was elevated. RAD23B was used as a loading control. (B) Exogenous expression of DDB2-Ndel/BP5KR made cells more sensitive to UVC. (C
and D) Repair kinetics of UV-induced 6-4PPs (C) and CPDs (D). The cells expressing DDB2-Ndel/BP5KR showed significantly slower repair of 6-4PPs
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complex was titrated in the presence of a fixed concentra-
tion of ubiquitin (Figure 7C). The competitive suppression
of polyubiquitination by XPC occurred regardless of which
sites in DDB2were modified, N-terminal tail or -propeller
domain (Supplementary Figure S9). On the basis of these
findings, we conclude that when XPC is recruited by UV-
DDB to sites with UV-induced photolesions, it can com-
petitively suppress poly-ubiquitination of DDB2 and thus
regulate its degradation.
DISCUSSION
Our previous studies revealed that seven lysine residues
within the structurally disordered N-terminal tail of human
DDB2 are the major targets of UV-induced ubiquitination
by CRL4DDB2, and thus regulate its degradation by the pro-
teasome (22). Here, we show that the DDB2N-terminal tail
plays an important role in cellular responses to UV. Exoge-
nous expression of DDB2-WT conferred marked UV resis-
tance on a normal human fibroblast cell line, but this ef-
fect was differentially abrogated by variousmutations intro-
duced into the N-terminal tail; changing all seven lysines to
arginines completely abolished the UV resistance conferred
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by DDB2, whereas deletion of the N-terminal tail had a
much smaller effect. It is notable that these exogenously ex-
pressedDDB2 proteins exerted dominant effects on cellular
responses toUV even in the presence of endogenousDDB2.
Because both DDB2-Ndel and DDB2-N7KR were re-
sistant to UV-induced degradation, the observed differ-
ence suggests additional roles for the N-terminal tail
besides regulation of ubiquitination and degradation.
The serine/threonine kinase p38 MAPK phosphorylates
DDB2, and this modification is involved in regulation of
chromatin remodeling and DDB2 stability (44). Although
the exact sites targeted by p38 MAPK have not been
identified, proteomic approaches revealed that at least ser-
ines 24 and 26 of DDB2 undergo phosphorylation in vivo
(45,46). Moreover, poly(ADP-ribosyl)ation occurs at lysine
residues within the N-terminal tail; this modification sup-
presses degradation of DDB2 and recruits the chromatin
remodeling factor ALC1 (47). Taken together, these ob-
servations suggest that multiple post-translational mod-
ifications, including ubiquitination, phosphorylation and
poly(ADP-ribosyl)ation, functionally interact with each
other and coordinately regulate the stability of DDB2 and
GG-NERoverall. On the other hand, DDB2 and the tumor
suppressor p53 mutually influence each other’s functions
(32,48,49), although the role ofDDB2 in the p53-dependent
apoptosis pathway remains controversial (50–55). The pre-
cise molecular mechanism underlying DDB2–p53 interac-
tions remains to be elucidated, but it is possible that the N-
terminal tail of DDB2 interacts with protein factors that
mediate DNA damage signaling upstream p53. If so, the
7KR mutations in the N-terminal tail may block lysine-
targeted modifications, but still allow interaction with cer-
tain proteins.
Based on the in vitro ubiquitination system contain-
ing CRL4DDB2 ligase, we previously showed that poly-
ubiquitination, but not mono-ubiquitination, of DDB2
abolishes its highly specific and potent interaction with UV-
damaged DNA (30). Although repair of UV-induced pho-
tolesions is stimulated by UV-DDB in vivo, the impact of
UV-DDB on the cell-free NER reaction remains some-
what obscure; in particular, in the absence of ubiquitina-
tion, UV-DDB inhibits in vitro repair of 6-4PPs, probably
due to its extraordinarily strong binding to this type of le-
sion (30,56,57). Because the affinities of UV-DDB andXPC
for DNA photolesions are quite different, we hypothesized
that poly-ubiquitination of DDB2may stimulate its dissoci-
ation from a photolesion and, consequently, promote han-
dover of damage to XPC (30,36). In addition to the ubiqui-
tination sites in the N-terminal tail, we identified additional
potential sites in the -propeller domain of DDB2, and
demonstrated that poly-ubiquitination abrogated the dam-
aged DNA-binding activity of DDB2 regardless of which
sites were modified. Based on these results, we generated
a novel DDB2 mutant (DDB2-Ndel/BP5KR) that was al-
most completely resistant to ubiquitination at least in vitro.
When expressed in a normal humanfibroblast cell line, how-
ever, this mutant protein remained bound to chromatin fol-
lowing UV irradiation for a longer period than other mu-
tants, but eventually reverted to the soluble fraction. Al-
though this observation suggests that poly-ubiquitination
may not play an essential role in dissociation of DDB2 from
the sites with photolesions, we cannot rule out the possibil-
ity that DDB2-Ndel/BP5KR still undergoes ubiquitination
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Figure 6. XPC suppresses UV-induced degradation of endogenously expressedDDB2 protein. (A) Behaviors of endogenousDDB2 inWI38VA13 (normal)
and XP4PASV (XPC-deficient) cells after UV-C irradiation at 10 J/m2. Cells were treated with cycloheximide (CHX) and fractionated as in Figure 2. (B)
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(C) Exogenous XPC expression suppressed UV-induced destabilization of endogenous DDB2 in XP4PASV cells. Treatment with CHX, UV irradiation
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insoluble materials [ppt] fractions) were determined from band intensities in (A) and (C), and plotted as a function of time after UV irradiation (DDB2
levels in the lanes labeled ‘0’ are defined as 100%). Mean values and standard errors were calculated from two independent experiments.
in vivo at cryptic sites, albeit with lower efficiency. Alterna-
tively, unknown mechanisms may exist by which XPC can
displace UV-DDB from the damaged sites, with or with-
out the aid of other factors. Nevertheless, expression of
DDB2-Ndel/BP5KR affected cellular NER functions, es-
pecially repair of 6-4PPs (Figure 4C), so that the observed
persistence of the mutant DDB2 on chromatin (Figure 4E)
may be associated with a defect in some early steps of
NER following DNA binding by UV-DDB. Furthermore,
among the isolated cell lines, DDB2-Ndel/BP5KR was ex-
pressed only at a significantly lower level than other DDB2
proteins, while expression of endogenous DDB2 seemed
to be elevated instead (Figure 4A). Given that such non-
ubiquitinatable DDB2 could be harmful to proliferating
cells due to its rather stable association with chromatin, se-
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lection may have been made so as to compensate for the
problem by up-regulating endogenous DDB2.
The most striking finding of this study was the obser-
vation that the stability of endogenously expressed DDB2
protein is positively regulated by XPC; therefore, when
XPC is expressed at higher levels, UV-induced degrada-
tion of DDB2 is accordingly less pronounced. Taken to-
gether with suppression of DDB2 auto-ubiquitination in
vitro, this finding suggests that XPC recruited to the UV-
DDB-bound sites preferentially absorbs ubiquitination by
the CRL4DDB2 ligase, and thereby protects DDB2 from
ubiquitination and degradation.WhenXPC is not recruited
in an appropriate manner, CRL4DDB2 may be forced to tar-
get DDB2, which is then targeted for degradation. This
model is of substantial biological relevance because it an-
swers a longstanding question regarding why DDB2 needs
to be degraded after a damage-recognition event despite
the persistence of unrepaired photolesions. Many studies,
including those of our group, have reported UV-induced
degradation of ectopically expressed, tagged DDB2. Be-
cause themodel delineated above implies that themolar bal-
ance between DDB2 and XPC is a critical factor affecting
stability of DDB2, one can assume that overexpression of
DDB2 itself evokes the overall destabilization of the pro-
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tein. Moreover, as shown in Figure 6D, the intensity of en-
dogenous (unmodified) DDB2 bands decreases transiently
after UV irradiation even in the presence of overexpressed
XPC. This observation suggests that protection by XPC of
DDB2 from ubiquitination may not be complete, whereas
the level of such DDB2 ubiquitination is nonetheless in-
sufficient for recognition by the proteasome; thus deubiq-
uitination may play a role in regulation of DDB2 as well
as XPC, as reported recently (37). Despite in vivo evidence
for recruitment of XPC by UV-DDB, assembly of the two
damage-recognition factors on a single DNA lesion has not
been demonstrated in vitro. Further biochemical and struc-
tural studies are necessary to elucidate howXPC suppresses
ubiquitination of DDB2.
According to our model, it is preferable for activation
of the CRL4DDB2 ligase to be suppressed until XPC is re-
cruited. Previously, activation of the Cullin-based E3 lig-
ase families was suggested to involve multiple steps of reg-
ulation (58). Our previous study indicated that the COP9
signalosome, an eight-subunit regulatory complex that sup-
presses ligase activity (59,60), is sterically displaced by the
interaction of CRL4DDB2 with damaged DNA (22). An-
other critical factor in this process is conjugation of Cullins
to the ubiquitin-like protein NEDD8. This modification in-
duces a structural change in the Cullin–RBX1 subcomplex,
causing it to adopt an opened conformation, by which the
catalytic center for ubiquitination acquires a more flexible
configuration; this structural alteration, in turn, prevents in-
teraction with CAND1, another inhibitor of Cullins (61).
Although the mechanism underlying regulation of CUL4
NEDDylation in CRL4DDB2 remains to be understood, the
presence or absence of XPC may affect this process, and
thereby modulate the spatial range and substrate selectiv-
ity of ubiquitination. On the other hand, in the absence of
XPC, full activation of CRL4DDB2 may not occur promptly
upon DNA binding, whereas the N-terminal tail of DDB2
is eventually ubiquitinated, leading to release of DDB2
from the damage site and its subsequent degradation. Our
cell-free systemmay not be appropriate for investigations of
these regulatory mechanisms, because the purified recom-
binant CRL4DDB2 ligase is constitutively active, and XPC
probably interacts only with a portion of the DDB2 in-
cluded in the reaction. Further studies using a more refined
system that recapitulates in vivo regulation should shed light
on these issues.
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